FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1530534806> ?p ?o ?g. }

• W1530534806 endingPage "1024" @default.
• W1530534806 startingPage "1002" @default.
• W1530534806 abstract "With the expanding list of medications available to treat patients with inflammatory bowel disease (IBD), it is important to recognise adverse events, including those involving the skin. Dermatological adverse events may be confused with extra-intestinal manifestations of IBD.To review drug-related dermatological manifestations associated with immunosuppressive and anti-tumour necrosis factor (anti-TNF) therapy.The literature was searched on PubMed for dermatological adverse events in IBD.Present thiopurine exposure was associated with a 5.9-fold [95% confidence interval (CI), 2.1-16.4] increased risk of developing non-melanoma skin cancer (NMSC). The peak incidence is highest in Caucasians over the age of 65 years with crude incidence rates of 4.0 and 5.7/1000 patient-years for present and previous use. In anti-TNF-exposed subjects, drug-induced lupus was reported in 1% of the cases and a psoriatic rash in up to 3% of the cases. Anti-TNF monotherapy increases the risk of NMSC ~2-fold to a rate of 0.5 cases per 1000 person-years. Cutaneous lymphomas have been rarely reported in subjects on thiopurine or anti-TNF drug monotherapy. Combination therapy seems to have an additive effect on the risk of developing NMSC and lymphoma.Physicians need to be aware of the wide spectrum of dermatological complications of immunosuppressive and anti-TNF therapy in IBD, especially psoriasis and non-melanoma skin cancer. Vigilance and regular screening for non-melanoma skin cancer is recommended. Case discussions between gastroenterologists and dermatologists should be undertaken to best manage dermatological adverse events." @default.
• W1530534806 created "2016-06-24" @default.
• W1530534806 creator A5008149243 @default.
• W1530534806 creator A5009073100 @default.
• W1530534806 creator A5024466587 @default.
• W1530534806 creator A5027876343 @default.
• W1530534806 creator A5033265431 @default.
• W1530534806 creator A5043687795 @default.
• W1530534806 creator A5063146539 @default.
• W1530534806 creator A5068927209 @default.
• W1530534806 creator A5069367391 @default.
• W1530534806 creator A5072015894 @default.
• W1530534806 creator A5072818285 @default.
• W1530534806 creator A5075694682 @default.
• W1530534806 creator A5083616352 @default.
• W1530534806 date "2013-09-25" @default.
• W1530534806 modified "2023-09-27" @default.
• W1530534806 title "Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease" @default.
• W1530534806 cites W1468337620 @default.
• W1530534806 cites W1482448048 @default.
• W1530534806 cites W1496217134 @default.
• W1530534806 cites W1504344248 @default.
• W1530534806 cites W1518420099 @default.
• W1530534806 cites W1527093917 @default.
• W1530534806 cites W1571860096 @default.
• W1530534806 cites W1573058660 @default.
• W1530534806 cites W1597614503 @default.
• W1530534806 cites W1865936106 @default.
• W1530534806 cites W1898779455 @default.
• W1530534806 cites W1902771600 @default.
• W1530534806 cites W1910112204 @default.
• W1530534806 cites W1966555727 @default.
• W1530534806 cites W1968908522 @default.
• W1530534806 cites W1969629625 @default.
• W1530534806 cites W1969867334 @default.
• W1530534806 cites W1971523253 @default.
• W1530534806 cites W1972295465 @default.
• W1530534806 cites W1976273679 @default.
• W1530534806 cites W1976546496 @default.
• W1530534806 cites W1976730809 @default.
• W1530534806 cites W1977265208 @default.
• W1530534806 cites W1977366147 @default.
• W1530534806 cites W1979198841 @default.
• W1530534806 cites W1979251453 @default.
• W1530534806 cites W1980274986 @default.
• W1530534806 cites W1980751609 @default.
• W1530534806 cites W1981383482 @default.
• W1530534806 cites W1982039040 @default.
• W1530534806 cites W1983306049 @default.
• W1530534806 cites W1983943495 @default.
• W1530534806 cites W1984557196 @default.
• W1530534806 cites W1986109277 @default.
• W1530534806 cites W1987493451 @default.
• W1530534806 cites W1987893275 @default.
• W1530534806 cites W1987925515 @default.
• W1530534806 cites W1989702104 @default.
• W1530534806 cites W1991311233 @default.
• W1530534806 cites W1991688187 @default.
• W1530534806 cites W1991810959 @default.
• W1530534806 cites W1993758696 @default.
• W1530534806 cites W1996455588 @default.
• W1530534806 cites W1996472975 @default.
• W1530534806 cites W1996579697 @default.
• W1530534806 cites W1997967918 @default.
• W1530534806 cites W1999141057 @default.
• W1530534806 cites W2000999105 @default.
• W1530534806 cites W2001478786 @default.
• W1530534806 cites W2002780176 @default.
• W1530534806 cites W2003391401 @default.
• W1530534806 cites W2004210867 @default.
• W1530534806 cites W2005097349 @default.
• W1530534806 cites W2005389248 @default.
• W1530534806 cites W2005490856 @default.
• W1530534806 cites W2007533329 @default.
• W1530534806 cites W2007725323 @default.
• W1530534806 cites W2007891117 @default.
• W1530534806 cites W2009094377 @default.
• W1530534806 cites W2010753554 @default.
• W1530534806 cites W2014976260 @default.
• W1530534806 cites W2015682764 @default.
• W1530534806 cites W2016321388 @default.
• W1530534806 cites W2017295150 @default.
• W1530534806 cites W2018010476 @default.
• W1530534806 cites W2018107500 @default.
• W1530534806 cites W2019886362 @default.
• W1530534806 cites W2020350753 @default.
• W1530534806 cites W2020374736 @default.
• W1530534806 cites W2021614259 @default.
• W1530534806 cites W2021946977 @default.
• W1530534806 cites W2024763754 @default.
• W1530534806 cites W2025044053 @default.
• W1530534806 cites W2027491899 @default.
• W1530534806 cites W2027559580 @default.
• W1530534806 cites W2030005741 @default.
• W1530534806 cites W2030234722 @default.
• W1530534806 cites W2030324611 @default.
• W1530534806 cites W2031022342 @default.
• W1530534806 cites W2032306536 @default.

• next